What is the address of Farmaka?

The registered office of Farmaka is located at Brusselsesteenweg 50, 2800 Mechelen.

Is Farmaka still active?

Yes. According to the CBE (29 October 2026) Farmaka is active, legal situation “Normale toestand”, started on 22 January 1972.

Is Farmaka registered on Peppol?

Yes, Farmaka is registered on the Peppol network with ID 0208:0412024227.

What is the enterprise number of Farmaka?

The enterprise number of Farmaka is BE0412024227.

When was Farmaka founded?

Farmaka was founded on 22 January 1972.

Who are the directors of Farmaka?

According to the 2025 annual accounts, the directors of Farmaka are: CHANTAL LEIRS, ANNIE DE SUTTER, CAROLINE LEBBE, GODFRIED NIESTEN, DESSIE ROOTHANS, CHRIS VAN HAECHT, EVELYN MACKEN.

Is Farmaka a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 January 1972; 4 annual accounts filed, latest fiscal year 2025; 7 directors known from the annual account.

How much profit did Farmaka make in 2025?

Farmaka recorded a loss after taxes of € 69,602 in financial year 2025.

What is the revenue of Farmaka?

As a small company, Farmaka is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -68,679.

Farmaka (Non-profit) - Mechelen - BE0412024227

Dossier Farmaka, printed on 29 October 2026 from databakkes.be/en/0412024227/farmaka. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

Farmaka from Mechelen, company number BE0412024227, closed financial year 2025 with a result of € -69,602 after tax. For that financial year Farmaka recorded a gross margin of € -68,679 and equity of € 303,686. Compared with financial year 2024, the result moved from € -17,061 to € -69,602. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.

What it is worth Healthy

€ 303,686

▼ 19% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -69,602

▼ 308 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 303,686

▼ 19% vs 2024

Cash and bank balances on the last day of the fiscal year.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2024	2025	Change 2024 → 2025
Gross margin	€ -221 Gross margin 2021: € -221 First fiscal year in the series	€ -2,732 Gross margin 2022: € -2,732 ▼ € 2,511 vs 2021 (€ -221) Unfavourable step	€ -16,998 Gross margin 2024: € -16,998 ▼ € 14,266 vs 2022 (€ -2,732) Unfavourable step	€ -68,679 Gross margin 2025: € -68,679 ▼ € 51,681 vs 2024 (€ -16,998) Unfavourable step	▼ € 51,681
Profit after taxes	€ -265 Profit after taxes 2021: € -265 First fiscal year in the series	€ -2,729 Profit after taxes 2022: € -2,729 ▼ € 2,464 vs 2021 (€ -265) Unfavourable step	€ -17,061 Profit after taxes 2024: € -17,061 ▼ € 14,332 vs 2022 (€ -2,729) Unfavourable step	€ -69,602 Profit after taxes 2025: € -69,602 ▼ € 52,541 vs 2024 (€ -17,061) Unfavourable step	▼ € 52,541
Equity	€ 396,055 Equity 2021: € 396,055 First fiscal year in the series	€ 393,326 Equity 2022: € 393,326 ▼ 1% vs 2021 (€ 396,055) Unfavourable step	€ 373,289 Equity 2024: € 373,289 ▼ 5% vs 2022 (€ 393,326) Unfavourable step	€ 303,686 Equity 2025: € 303,686 ▼ 19% vs 2024 (€ 373,289) Unfavourable step	▼ 19%
Total debts	€ 4,972 Total debts 2021: € 4,972 First fiscal year in the series	€ 0 Total debts 2022: € 0 ▼ 100% vs 2021 (€ 4,972) Favourable step	€ 288 Total debts 2024: € 288 Unchanged (€ 0) Unfavourable step	€ 0 Total debts 2025: € 0 ▼ 100% vs 2024 (€ 288) Favourable step	▼ 100%
Cash	€ 395,986 Cash 2021: € 395,986 First fiscal year in the series	€ 393,326 Cash 2022: € 393,326 ▼ 1% vs 2021 (€ 395,986) Unfavourable step	€ 373,576 Cash 2024: € 373,576 ▼ 5% vs 2022 (€ 393,326) Unfavourable step	€ 303,686 Cash 2025: € 303,686 ▼ 19% vs 2024 (€ 373,576) Unfavourable step	▼ 19%
Retained profit	€ 284,930 Retained profit 2021: € 284,930 First fiscal year in the series	€ 282,201 Retained profit 2022: € 282,201 ▼ 1% vs 2021 (€ 284,930) Unfavourable step	€ 262,164 Retained profit 2024: € 262,164 ▼ 7% vs 2022 (€ 282,201) Unfavourable step	€ 192,562 Retained profit 2025: € 192,562 ▼ 27% vs 2024 (€ 262,164) Unfavourable step	▼ 27%
Balance sheet total	€ 401,027 Balance sheet total 2021: € 401,027 First fiscal year in the series	€ 393,326 Balance sheet total 2022: € 393,326 ▼ 2% vs 2021 (€ 401,027) Unchanged	€ 373,576 Balance sheet total 2024: € 373,576 ▼ 5% vs 2022 (€ 393,326) Unchanged	€ 303,686 Balance sheet total 2025: € 303,686 ▼ 19% vs 2024 (€ 373,576) Unchanged	▼ 19%

Key figures of Farmaka, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Farmaka?

What happened at Farmaka in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2030 DESSIE ROOTHANS stepped down as director. NBB
2029 CHANTAL LEIRS stepped down as director. NBB
2029 ANNIE DE SUTTER stepped down as director. NBB
2029 CHRIS VAN HAECHT stepped down as director. NBB
2028 CAROLINE LEBBE stepped down as director. NBB
2028 GODFRIED NIESTEN stepped down as director. NBB
2028 EVELYN MACKEN stepped down as director. NBB
Jun 23, 2026 New annual accounts for financial year 2025: loss of € 69,602. Source: NBB ↗

In short

From € 266 loss in 2021 to € 69,602 loss in 2025.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2025 annual accounts

CHANTAL LEIRS

Director

since 2025 · until 2029

ANNIE DE SUTTER

Director

Also active at: IDESA

since 2025 · until 2029

CAROLINE LEBBE

Director

since 2018 · until 2028

GODFRIED NIESTEN

Director

since 2019 · until 2028

DESSIE ROOTHANS

Director

since 2026 · until 2030

CHRIS VAN HAECHT

Director

since 2025 · until 2029

EVELYN MACKEN

Director

since 2008 · until 2028

Establishments

Establishment units

Physical locations of this company

Registered office

Brusselsesteenweg 50

2800 Mechelen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0412.024.227
VAT number: BE 0412.024.227
Registered office: Brusselsesteenweg 50, 2800 Mechelen
Names & denominations: Farmaka
Enterprise type: Rechtspersoon
Legal form: Non-profit association
Legal situation: Normale toestand
Start date: 22 January 1972
Peppol: Active · Active since 23 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

Farmaka

Warning lights

Financials

What happened to Farmaka?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions